When was ViewsML founded?

ViewsML was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Where is ViewsML located?

ViewsML is headquartered in Vancouver, Canada.

How many employees does ViewsML have?

As of Mar 31, 2026, the latest employee count at ViewsML is 11.

Is ViewsML a funded company?

ViewsML is a funded company, having raised a total of $3.58M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2024.

When was the latest funding round of ViewsML?

ViewsML's latest funding was a $***** Seed round on Apr 20, 2026, with participation from 8 investors.

Where does ViewsML rank among its competitors?

ViewsML ranks 55th amongst 307 active competitors, of which 87 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ViewsML, which secured $3.58M in Apr, 2026.

Who are the top competitors of ViewsML?

ViewsML's top competitors include PAIGE, PathAI and Ibex. Among them, ViewsML secured the most recent funding round in April, 2026.

ViewsML - 2026 Company Profile, Team, Funding & Competitors

ViewsML is a seed company based in Vancouver (Canada), founded in 2022 by Rafay A. It operates as an AI-powered platform for drug development and companion diagnostics. ViewsML has raised $3.58M in funding from Wittington Ventures and PAX Momentum. The company has 307 active competitors, including 87 funded and 16 that have exited. Its top competitors include companies like PAIGE, PathAI and Ibex.

Company Details

AI-powered platform for drug development and companion diagnostics. The company's key platform technology, Aion, virtualizes the IHC process to forecast biomarker expression spatially and increase efficiencies in drug discovery, as well as hasten patient selection in clinical trials.

Website: www.viewsml.com/
Email ID: *****@viewsml.com
Phone Number: +1 **********

Key Metrics

Founded Year

2022

Location

Vancouver, Canada

Stage

Seed

Total Funding

$3.58M in 3 rounds

Latest Funding Round

Seed, Apr 20, 2026, $*****

Investors

Wittington Ventures & 9 more

Ranked

55^th among 307 active competitors

Employee Count

11 as on Mar 31, 2026

Similar Companies

PAIGE & 330 more

View ViewsML's full profile

ViewsML has raised a total funding of $3.58M over 3 rounds. Its first funding round was on 2024. Its latest funding round was a Seed round on Apr 20, 2026 for $*****. 8 investors participated in its latest round. ViewsML has 10 institutional investors.

Here is the list of recent funding rounds of ViewsML:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 20, 2026	7943092	Seed	1955256	7703475	8057329	8990335
2024	8759	Seed	7983	3640	6793	RiSC Capital
2024	7934	Seed	4799	9246	PAX Momentum	2590

Access funding benchmarks and valuations. Sign up today!

View details of ViewsML's funding rounds and investors

The founders of ViewsML is Rafay A. Kenneth To is the CEO of ViewsML.

Here are the details of ViewsML's key team members:

Rafay A: Co-Founder of ViewsML.
Kenneth To: CEO of ViewsML.

View details of ViewsML's Founder profiles and Board Members

ViewsML's employee count trend

ViewsML has 11 employees as of Mar 26. Here is ViewsML's employee count trend over the years:

Uncover ViewsML's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ViewsML include PAIGE, PathAI and Ibex. Here is the list of Top 10 competitors of ViewsML, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	70/100
3rd	Ibex 2016, Tel Aviv (Israel), Series C	Provider of AI-powered diagnostic solutions for pathology	$114M	83NORTH, aMoon & 6 others	69/100
4th	Pictor Labs 2019, Los Angeles (United States), Series B	AI-based solutions for pathological image analysis	$48.8M	Insight Partners, LabCorp & 4 others	64/100
5th	Aignostics 2018, Berlin (Germany), Series B	Provider of AI-driven solutions for drug development and precision medicine	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
6th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Businessfinland, Ascend Capital Partners & 8 others	63/100
7th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
8th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	62/100
9th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$35.4M	ARUP Laboratories, Zoetis & 1 others	60/100
10th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, Insight Partners ... & 22 others	59/100
55th	ViewsML 2022, Vancouver (Canada), Seed	AI-powered platform for drug development and companion diagnostics	$3.58M	Debiopharm, Mayo Clinic & 8 others	41/100